Clariant is marking the 10th anniversary of the launch of the MEVOPUR ‘medical-grade’ materials portfolio with the introduction of a theme: The Color of Innovation - The Science of Design.
Clariant
Clariant marks 10 years of MEVOPUR at MD&M West
The new branding, which is being launched in conjunction with the anniversary, is aimed at capturing the unique nature of the MEVOPUR family of products and services, encompassing compounds and concentrates, medical and pharma regulatory support, and support with change control embedded in the GMP quality system.
It is the focus of Clariant’s exhibit at MD&M West 2020 (11-13 February).
Steve Duckworth, Global Head of Marketing and Business Development, said: “Even after 10 years, no other company in the plastics industry has anything like MEVOPUR. We apply multi-industry problem-solving expertise grounded in deep technical and regulatory knowledge to help ensure the safety, compliance and performance of our customers’ products throughout the manufacturing process and beyond – so they can get to market on time and on budget.”
Since 2010, a dedicated team of Clariant healthcare polymer solution experts has been building a deep technical and regulatory understanding in order to help medical device and pharmaceutical companies deliver products that look great, perform at the highest levels and readily meet compliance requirements.
All MEVOPUR materials – including colour and additive concentrates and ‘ready-to-use’ polymer compounds – are produced in three dedicated EN:ISO13485-2016 registered facilities and have been pre-tested to support compliance needs of customers in US and Europe.
In just the last few years, Clariant has invested heavily to boost compounding capacity at its plant in Lewiston, Maine (USA), and will soon announce expansions in Asia.